The world is fast. Thousands of news is pouring out a day, but it is not easy to find articles that illuminate the field from a new perspective. In response to this, News Today visits the vivid scene and wants to communicate the same questions and answers to the reader and expand the empathy. [편집자 주]
Kim Kyung -hee, director of Innovottera Futics, explains ‘Motifool’. [사진=이노보테라퓨틱스]
[뉴스투데이=서민지 기자] New Drug Development -based Bioventure Inovottera Futics has launched a global market with a hair loss care brand ‘Motiful’. Interest in the hair loss shampoo market is focused on the use of its own development ingredients and AI platforms beyond the existing market limits.
According to the Korean Society for Malmo Treatment on the 23rd, the domestic hair loss population is estimated at about 10 million. About 20%of the population of the Republic of Korea is suffering from hair loss, and the proportion of 2030 patients and women is also increasing rapidly. In the meantime, existing hair loss treatments are limited to some ingredients, revealing limitations in treatment.
Innovoteraputics Motipul launched ‘Hair Boosting Ampoule Tonic’ in March to solve the root cause of hair loss.
Kim Kyung -hee, director of Innovotera Futics, who led the product development, said in a written interview with News Today, saying, “Moti Pool started with a problem of seeing hair loss as a challenge of human beings, not just a beauty issue.”
■ Existing hair loss care market blank … Filled with its own ingredient ‘Trinogenix®’
The existing hair loss care market has relied on limited drugs such as Pinasteride, Dutasteride and Minoxidil. These drugs are difficult to use for a long time due to side effects, and cosmetics and functional products often stay at the level of scalp care or temporary thickness improvement. In other words, there was a lack of innovative alternatives to fundamentally improve hair loss by acting deep into the hair follicles.
Researchers, including Kim, developed a low molecular new material complex ‘Trinogenix®’ to control molecular targets that have been proven hair loss mechanisms. This ingredient is △ Innovodol, which promotes hair follicle regeneration by increasing prostaglandin E2, △ innovozol to prevent hair loss progression by suppressing prostagland D2, △ antioxidant and party metabolic control to help hair growth It consists of three substances: ‘Innovoridine’.
‘Trinogenix®’ showed interesting results in clinical trials. The team conducted a human application test for 24 weeks hair loss people, and has already confirmed the effective improvement of hair loss from the 8th week.
Kim said, “In the industry, it is usually significant in 16 weeks or 24 weeks, but it is significant in that the motifle has proved its effect at a much faster time.”
‘Hair Boosting Ampoule Tonic’ product production image. [사진=이노보테라퓨틱스]
■ The goal is ‘3 ingredient melting’
Kim Kyung -hee cited as an improvement task of melting three components to commercialize ‘Trinogenix®’. All three ingredients are powdered in the form of powder. The team succeeded in melting with a lot of experiments and combinations, but also met unexpected walls in the commercialization stage.
Kim recalled, “The first OEM manufacturer with the first OEM manufacturer said that it was difficult to produce because of the specificity of the ingredients.”
Kim collaborated closely with a new manufacturing partner with conviction that it is essential for improving hair loss. As a result, it was solved by the Zenix holding technique that stably formulated ‘Trinogenix®’, and the current motifle was born.
The team also used AI to ensure the effectiveness and safety of ‘Trinogenix®’. The team derived a stable protein structure through the AI new drug development platform ‘Deepzema’. Deep Zema predicted the bonding power and efficacy between each target protein and candidate materials, and minimized the risk of side effects by predicting the possibility of acting on other proteins that did not want.
Kim said, “Dipjema has only worked on the hair follicles and analyzed the possibility that there is no toxicity through the molecular structure that is not exposed to the systemic blood system.”
‘Hair Boosting Ampoule Tonic’ product production image. [사진=이노보테라퓨틱스]
■ Motifier, entering the United States at the same time … Global brand growth target
Motifool has developed an ampoule tonic that contains its own ingredients, which is expected to be approved for domestic functionality. In the United States, the ampoule tonic that utilizes only the ‘Trinogenix®’ single ingredients has been commercialized, and the US has made a new solution to the US as a strategic base market.
In July, he participated in the world’s largest beauty fair and received great attention from overseas buyers. At that time, it attracted attention in that it was made around the original ingredients that were directly researched and developed by new drug development -based bioventures.
Motifool is also expected to enter the global market such as Europe, Southeast Asia and Iraq.
Kim said, “Moti Pool is gaining attention from overseas markets in that it is not a different way of marketing by bringing raw materials proposed by general cosmetics manufacturers.”
In Korea, the company is expanding consumer contact points through experience groups, online sales and YouTube. Kim said, “It was a great meaning as a researcher by shooting and sharing the changes in hair and delivering specific opinions.”
‘Hair Boosting Ampoule Tonic’ product production image. [사진=이노보테라퓨틱스]
■ Market stabilization concentration … Hair loss care product line expansion plan
Moti Pool is trying to settle the market of ‘Hair Boosting Ampoule Tonic’, a core product. However, hair loss care will require differentiated access according to age and gender, so it plans to launch specialized products by checking consumer demand.
Kim said, “The specific point of view is not set, but we will analyze the actual experience and feedback of our customers and introduce the best product line sequentially.”
